EE57 Real-World Reductions in Migraine-Related Health Care Resource Utilization and Costs for Patients Initiating Fremanezumab: A 12-Month Retrospective US Claims Analysis
Autor: | Driessen, MT, Krasenbaum, LJ, Ramirez-Campos, V, DiEgidio, R, Tian, M, Seminerio, MJ |
---|---|
Zdroj: | In Value in Health July 2022 25(7) Supplement:S346-S346 |
Databáze: | ScienceDirect |
Externí odkaz: |